Abbott, MSD Partner to Boost Diabetes Drug Distribution Nationwide

In a significant move that intended to improve access diabetes care in India, global pharmaceutical leaders Abbott and MSD Pharmaceuticals have entered into a strategic partnership

Glenmark Receives USFDA Form 483 for Monroe Manufacturing Unit

Glenmark Pharmaceuticals announced on Wednesday that the US FDA issued a Form 483 with five procedural observations after an inspection of its Monroe Manufacturing Facility in North Carolina...

Revised Schedule M Puts Pressure on Small Drug Manufacturers

As the deadline has now passed, a large number of India’s small and mid-sized pharmaceutical manufacturers may be forced to shut down, as they have failed to provide required upgrade plans...

Welcure Expands Global Sourcing With Strategic Thai Partnership

Welcure Drugs & Pharmaceuticals announced on Wednesday that it has finalized a contract with Thailand-based Fortune Sagar Impex Compamy for third-party sourcing and procurement services totaling Rs 517 cr

Pharmaceutical Exports Climb 7.4% in May, Continuing Upward Trend

India's drug exports and pharmaceuticals posted a year-on-year increase of 7.4 percent to US dollar 2.47 billion in May 2025 from US dollar 2.31 billion in the corresponding month last year, based on Ministry of Commerce and Industry released data.

Alembic Pharma Gets USFDA EIR for API Unit in Gujarat

Alembic Pharmaceuticals Ltd reported on Wednesday, June 18, that it has received an Establishment Inspection Report (EIR) from the US Food and Drug Administration (USFDA) for its API-III manufacturing site, at Karakhadi, Gujarat...

USFDA Inspects Syngene's GCP Compliance in Bengaluru Facility

Syngene International shares are expected to be in focus after two major regulatory statements by the United States Food and Drug Administration (USFDA) on inspections at the company's Bengaluru-based facilities.

Bayer Seeks FDA Nod for Gadoquatrane as MRI Contrast Agent for CNS Use

Bayer has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for gadoquatrane, the firm's investigational gadolinium-based contrast agent for use in contrast-enhanced CNS and other body region MRI.

Boehringer Ingelheim launches three-in-one poultry vaccine in India

Boehringer Ingelheim, a global leader in animal health, has announced the launch of its latest poultry vaccine in India—a single-dose, next-generation solution that provides protection against Bursal, Newcastle and Marek’s disease...

New export push: DGFT opens 'Source from India' to more exporters

In a significant step toward strengthening India’s pharmaceutical and trade export ecosystem, the Directorate General of Foreign Trade (DGFT), Ministry of Commerce and Industry, has announced the launch of the ‘Source from India’ feature...

on the deck


Most Viewed

Editor's Guest


© 2025 India Pharma Outlook. All Rights Reserved.